Cell Therapy in Idiopathic Pulmonary Fibrosis† by Anna Serrano-Mollar

Get full text

Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis by Elena Lopez-Rodriguez, Elena Lopez-Rodriguez, Gemma Gay-Jordi, Gemma Gay-Jordi, Lars Knudsen, Lars Knudsen, Matthias Ochs, Matthias Ochs, Matthias Ochs, Anna Serrano-Mollar, Anna Serrano-Mollar

Get full text

Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model. by Gemma Gay-Jordi, Eduard Guash, Begoña Benito, Josep Brugada, Stanley Nattel, Lluís Mont, Anna Serrano-Mollar

Get full text

Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats by Raquel Guillamat-Prats, Marta Camprubí-Rimblas, Ferranda Puig, Raquel Herrero, Neus Tantinyà, Anna Serrano-Mollar, Antonio Artigas

Get full text

Differences and Similarities between the Lung Transcriptomic Profiles of COVID-19, COPD, and IPF Patients: A Meta-Analysis Study of Pathophysiological Signaling Pathways by Daniel Aguilar, Adelaida Bosacoma, Isabel Blanco, Olga Tura-Ceide, Anna Serrano-Mollar, Joan Albert Barberà, Victor Ivo Peinado

Get full text